Bottom line
GGHCX vs LYFIX: the short answer
GGHCX (INVESCO Health Care Fund) and LYFIX (AlphaCentric Life Sciences and Healthcare Fund) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.
GGHCX is cheaper at 1.07% vs 1.41% — a difference of $34 a year per $10,000 invested.
Over five years, LYFIX returned +5.6% a year vs +2.6% for GGHCX.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
GGHCX vs LYFIX side by side
| GGHCX | LYFIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Mutual |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.07% | 1.41% |
| Annual cost per $10k | $107 | $141 |
| 10-yr cost on $10k (prospectus) | $1,784 | $2,357 |
| Max front load | 5.5% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +9.2% | +28.2% |
| 5-yr return (annualized) | +2.6% | +5.6% |
| 10-yr return (annualized) | +5.8% | — |
| Best quarter | +19.6% | +27.5% |
| Worst quarter | −16.5% | −11.9% |
| Net assets (fund) | $1.2B | $46.6M |
| Number of holdings | 82 | 62 |
| Portfolio turnover | 59% | 107% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
5 of GGHCX's top 25 holdings also appear in LYFIX's top 25.
| Holding | GGHCX | LYFIX |
|---|---|---|
| AbbVie Inc. | 4.03% | 1.95% |
| Gilead Sciences, Inc. | 3.63% | 5.53% |
| argenx SE | 3.24% | 3.59% |
| Vertex Pharmaceuticals Inc. | 2.01% | 5.33% |
| Axsome Therapeutics, Inc. | 1.58% | 3.43% |
Source: SEC Form N-PORT
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
LYFIX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
FAQ
What is the difference between GGHCX and LYFIX?
Which is cheaper, GGHCX or LYFIX?
Should I own both GGHCX and LYFIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.